BIOMAT Database Logo BIOMAT Database Logo

Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue. 1973

D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D000432 Methanol A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness. Alcohol, Methyl,Carbinol,Sodium Methoxide,Wood Alcohol,Alcohol, Wood,Methoxide, Sodium,Methyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Systemic epithelioid granulomata following immunotherapy with methanol extracted residue of bacillus Calmette-Guérin.
April 1978, Cancer treatment reports,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Immunoprophylaxis with Calmette-Guérin bacillus in recurrent superficial bladder tumors.
January 1989, European urology,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Phase I toxicity study of methanol-extracted residue of Bacillus Calmette-Guérin by the iv route.
January 1979, Cancer treatment reports,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Effects of methanol extraction residue of Bacillus calmette-Guérin in humans.
April 1977, Cancer research,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Characterization of methanol extraction residue (MER) from Bacillus Calmette-Guérin (BCG).
October 1979, The Journal of antibiotics,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
April 1978, Cancer treatment reports,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-Guérin.
February 1979, Cancer treatment reports,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-Guérin.
January 1977, Cancer treatment reports,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
April 1980, Cancer research,
D H Lavrin, and S A Rosenberg, and R J Connor, and W D Terry
Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
December 1983, Cancer research,
Copied contents to your clipboard!